[HTML][HTML] Polyethylenimine (PEI) in gene therapy: Current status and clinical applications

J Casper, SH Schenk, E Parhizkar, P Detampel… - Journal of Controlled …, 2023 - Elsevier
Polyethlyenimine (PEI) was introduced 1995 as a cationic polymer for nucleic acid delivery.
PEI and its derivatives are extensively used in basic research and as reference formulations …

Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond)

U Lächelt, E Wagner - Chemical reviews, 2015 - ACS Publications
Since the elucidation of the molecular structure of nucleic acids and understanding of their
role in encoding and translating genetic information into biological function, 1 the knowledge …

MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction

R Song, C Dasgupta, C Mulder, L Zhang - Circulation, 2022 - Am Heart Assoc
Background: Ischemic heart disease remains a leading cause of death worldwide. In this
study, we test the hypothesis that microRNA-210 protects the heart from myocardial …

Knocking down barriers: advances in siRNA delivery

KA Whitehead, R Langer, DG Anderson - Nature reviews Drug …, 2009 - nature.com
In the 10 years that have passed since the Nobel prize-winning discovery of RNA
interference (RNAi), billions of dollars have been invested in the therapeutic application of …

Delivery of siRNA therapeutics: barriers and carriers

J Wang, Z Lu, MG Wientjes, JLS Au - The AAPS journal, 2010 - Springer
RNA interference is a naturally occurring endogenous regulatory process where short
double-stranded RNA causes sequence-specific posttranscriptional gene silencing. Small …

[HTML][HTML] Liposome-polymer complex for drug delivery system and vaccine stabilization

AK Umar, N Wathoni, JH Zothantluanga, S Das… - Heliyon, 2022 - cell.com
Liposomes have been used extensively as micro-and nanocarriers for hydrophobic or
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …

Interfering with disease: a progress report on siRNA-based therapeutics

A de Fougerolles, HP Vornlocher… - Nature reviews Drug …, 2007 - nature.com
RNA interference (RNAi) quietly crept into biological research in the 1990s when
unexpected gene-silencing phenomena in plants and flatworms first perplexed scientists …

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma

AF Ibrahim, U Weirauch, M Thomas, A Grünweller… - Cancer research, 2011 - AACR
MicroRNAs (miRNA) aberrantly expressed in tumors may offer novel therapeutic
approaches to treatment. miR-145 is downregulated in various cancers including colon …

Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo

P Zhupanyn, A Ewe, T Büch, A Malek… - Journal of Controlled …, 2020 - Elsevier
Extracellular vesicles (ECVs) are secreted cell-derived membrane particles involved in
intercellular signaling and cell-cell communication. By transporting various bio …

Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity

A Zintchenko, A Philipp, A Dehshahri… - Bioconjugate …, 2008 - ACS Publications
Polymer carriers like PEI which proved their efficiency in DNA delivery were found to be far
less effective for the applications with siRNA. In the current study, we generated a number of …